HealthNewsEMCO : No Residents Attempt to Flee Taman Meru 2C – Police0 Comments1 Min ReadIPOH, Nov 20 — The 2,168 residents of Zone B and C in Taman Meru 2C which…
HealthNewsKuala Terengganu Free from Haemorrhagic Septicaemia – Vet Dept0 Comments1 Min ReadKUALA TERENGGANU, Nov 20 — As of yesterday, Kuala Terengganu district has been declared free of haemorrhagic septicaemia…
HealthWomen Living Near Fracking Sites Are Likely To Have Preterm Birth – Study0 Comments2 Min ReadFracking is a slang term for hydraulic fracturing, which is the process of creating fractures in…
HealthNews5,252 Pints of Blood Collected by Sabah Red Crescent0 Comments1 Min ReadKOTA KINABALU, Nov 19 — The Malaysian Red Crescent (MRC) Sabah has collected 5,252 pints of blood to date…
HealthStudy Shows Vaping Can Make You Vulnerable With Viruses Like COVID-190 Comments2 Min ReadResearchers have found that e-cigarette smokers show suppression of immune genes critical to combat infections. A…
HealthCOVID-19 Positive Patients Still Don’t Believe Virus Is Real Even As They’re Dying On Bed – Nurse In Dakota0 Comments2 Min ReadJodi Doering, a registered ER nurse expresses how sorrowful she feels to the patients that are…
HealthNewsEMCO in Zone B & Zone C Taman Meru 2C, Ipoh Starting November 20 – Ismail Sabri0 Comments1 Min ReadZone B and Zone C areas in Taman Meru 2C, Ipoh will be implemented Enhanced Movement…
HealthNewsEMCO At Seberang Perai Prison, Seberang Perai Prison Housing Quarters Extended Until December 2- Ismail Sabri0 Comments1 Min ReadSenior Minister of Defense, Dato ’Sri Ismail Sabri Yaakob informed that the Enhanced Movement Control Order…
HealthNewsViral Pictures Of Foreign Workers Wearing ‘Pink Bracelets’, This Is What Tan Sri Dr. Noor Hisham Said0 Comments2 Min ReadPreviously, pictures of foreign workers wearing pink quarantine bracelets while working at a construction site have…
HealthModerna COVID-19 Vaccine 94.5% Effective In Second Breakthrough0 Comments2 Min ReadMorderna, a biotech company said on Monday that their early analysis from its Phase 3 trial…